FEATURES OF PHARMACOTHERAPY OF HEPATIC ENCEPHALOPATHY MANIFESTATIONS IN LIVER CIRRHOSIS
Journal Title: Health Problems of Civilization - Year 2015, Vol 9, Issue 2
Abstract
The aim of this work is to study the effect of drug mebikaron the clinical manifestations of hepatic encephalopathy in patients with liver cirrhosis. The study involved 34- patients with cirrhosis of different etiologies. The average age of the examined patients was (485109) years, that prevailed patients of working age, indicating the medical andsocial significance of the problem of early diagnosis and adequate treatment of cirrhosis. One of the most frequent complications of cirrhosis is hepatic encephalopathy. In addition to conventional clinical and laboratory findings in patients with liver cirrhosis, severities of hepatic encephalopathy were determined according to West-Haven criteria before and after treatment. In patients with liver cirrhosis was established the presence of latent or clinically expressed hepatic encephalopathy. The treatment of the control group of patients consisted of the following drugs: essential phospholipids, mixture of sorbitol and major ions, arginine glutamate, furosemide, verospiron, lactulose, amoxicillin trihydrate and lansoprazole. In the complex treatment of the main group of patients medicine mebikar was administered additionally. Analysis of the clinical manifestations of hepatic encephalopathy showed a marked improvement in patients who received additional treatment with mebikar. Specifically, the incidences of mood changes as well as anxiety decreased in this group on average of 38% compared with those patients without an additional treatment with mebikar. Also, sleep disturbances in the main group was observed to be lower by 7.2% compared to those in the control group. Inclusion in the treatment of patients with liver cirrhosis, the drug mebikar — a daytime tranquilizer with anxiolytic properties reduces neurotic disorders, improves emotional state which may indicate a regression in the manifestations of hepatic encephalopathy thereby improving the quality of life of patients and thus substantiating an expedient inclusion of mebikar an anxiolytic drug to the complex therapy of patients with liver cirrhosis.
Authors and Affiliations
Viktor Meretskyi, Natalya Lobanets
Keywords
Related Articles
- EP ID EP218924
- DOI 10.5114/hpc.2015.57111
- Views 76
- Downloads 0
Physical activity, physical development and eating habits within the lifestyle of students from Ukraine
The aim of this study was to investigate the physical activity, the basic parameters of physical development, and eating habits of students from Ukraine. The research method of diagnostic survey using a IPAQ questionnair...
Report from the 3rd International Scietific Conference “Physical activity in a healthy lifestyle”
.
SELECTED ELEMENTS OF THE ASSESSMENT OF EATING HABITS ON THE EXAMPLE OF 2ND and 3RD CLASSES OF HIGH SCHOOL
Aim The aim of this paper is the assessment of eating habits of high school students from grades 2 and 3, including eating habits, self-evaluation of diet and the most common nutrition mistakes committed by the members...
Place and role of physical activity in the lives of the elderly and disabled people
The role of physical activity in the healthy lifestyle is a recurring element of surveys at every stage of the human life. The fact that people live longer indicates a necessity for studying the issue of physical activit...
Types of leisure time activities among Lajkonik snacks company employees in Skawin
Aim of study. The aim of this study is to evaluate the size and the types of leisure-time activities with special regard to health-oriented behaviors among blue-collar and white-collar workers of the snacks company "Lajk...